| Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents EP Buddingh, ML Kuijjer, RAJ Duim, H Bürger, K Agelopoulos, ... Clinical Cancer Research 17 (8), 2110-2119, 2011 | 457 | 2011 |
| Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2 AB Mohseny, K Szuhai, S Romeo, EP Buddingh, I Briaire‐de Bruijn, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 340 | 2009 |
| Pediatric long‐COVID: An overlooked phenomenon? CLH Brackel, CR Lap, EP Buddingh, MA van Houten, ... Pediatric pulmonology 56 (8), 2495-2502, 2021 | 174 | 2021 |
| Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data ML Kuijjer, H Rydbeck, SH Kresse, EP Buddingh, AB Lid, H Roelofs, ... Genes, Chromosomes and Cancer 51 (7), 696-706, 2012 | 149 | 2012 |
| Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma JHW Pahl, SEN Ruslan, EP Buddingh, SJ Santos, K Szuhai, M Serra, ... Clinical cancer research 18 (2), 432-441, 2012 | 120 | 2012 |
| Prognostic factors in pulmonary metastasized high‐grade osteosarcoma EP Buddingh, JK Anninga, MIM Versteegh, AHM Taminiau, RM Egeler, ... Pediatric blood & cancer 54 (2), 216-221, 2010 | 110 | 2010 |
| Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells EP Buddingh, MW Schilham, SEN Ruslan, D Berghuis, K Szuhai, ... Cancer immunology, immunotherapy 60, 575-586, 2011 | 109 | 2011 |
| Chromosome 6 abnormalities are recurrent in synovial chondromatosis EP Buddingh, P Krallman, JR Neff, M Nelson, J Liu, JA Bridge Cancer genetics and cytogenetics 140 (1), 18-22, 2003 | 99 | 2003 |
| No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas CMA Reijnders, CJF Waaijer, A Hamilton, EP Buddingh, SPD Dijkstra, ... The American journal of pathology 177 (4), 1946-1957, 2010 | 81 | 2010 |
| Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis D Berghuis, MW Schilham, HI Vos, SJ Santos, S Kloess, EP Buddingh', ... Clinical sarcoma research 2, 1-13, 2012 | 78 | 2012 |
| Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy ML Kuijjer, BEWM van den Akker, R Hilhorst, M Mommersteeg, ... BMC medical genomics 7, 1-12, 2014 | 68 | 2014 |
| Cytogenetic findings in benign cartilaginous neoplasms EP Buddingh, S Naumann, M Nelson, JR Neffa, N Birch, JA Bridge Cancer genetics and cytogenetics 141 (2), 164-168, 2003 | 52 | 2003 |
| Improved diagnosis of viral encephalitis in adult and pediatric hematological patients using viral metagenomics EC Carbo, EP Buddingh, E Karelioti, IA Sidorov, MCW Feltkamp, ... Journal of Clinical Virology 130, 104566, 2020 | 51 | 2020 |
| Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis AFAD Schauwvlieghe, AG Vonk, EP Buddingh, RAS Hoek, VA Dalm, ... Journal of Antimicrobial Chemotherapy 72 (11), 3047-3050, 2017 | 32 | 2017 |
| Multisystem inflammatory syndrome in children in Western countries? Decreasing incidence as the pandemic progresses?: An observational multicenter international cross-sectional … D Buonsenso, A Perramon, M Català, JP Torres, G Camacho-Moreno, ... The Pediatric infectious disease journal 41 (12), 989-993, 2022 | 25 | 2022 |
| Interferon-gamma immunotherapy in a patient with refractory disseminated candidiasis EP Buddingh, J Leentjens, J van der Lugt, WA Dik, MS Gresnigt, ... The Pediatric Infectious Disease Journal 34 (12), 1391-1394, 2015 | 25 | 2015 |
| Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients EP Buddingh, SEN Ruslan, D Berghuis, H Gelderblom, JK Anninga, ... Cancer Immunology, Immunotherapy 61, 941-947, 2012 | 19 | 2012 |
| Neurocognitive, psychosocial, and quality of life outcomes after multisystem inflammatory syndrome in children admitted to the PICU MH Otten, CMP Buysse, EP Buddingh, SWJ Terheggen-Lagro, ... Pediatric critical care medicine 24 (4), 289-300, 2023 | 17 | 2023 |
| Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS … W Feleszko, M Okarska‐Napierała, EP Buddingh, M Bloomfield, A Sediva, ... Pediatric Allergy and Immunology 34 (1), e13900, 2023 | 17 | 2023 |
| Reinfection with severe acute respiratory syndrome coronavirus 2 without recurrence of multisystem inflammatory syndrome in children EP Buddingh, ACTM Vossen, HJ Lamb, RLF Van Der Palen, ... The Pediatric Infectious Disease Journal 40 (12), e491-e492, 2021 | 17 | 2021 |
